Related Experiment Video
Updated: May 15, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
231
[Immune Checkpoints Mediate Tumor Immune Regulation through Metabolic Pathways]
Weiguang Du1, Xiyang Tang2, Yulong Zhou2
1Graduate School of Xi'an Medical University, Xi'an 710021, China.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|April 10, 2025
Summary
Immune checkpoints regulate cell metabolism, impacting cancer treatment effectiveness. Targeting both checkpoints and metabolic pathways may overcome tumor immune resistance.
Area of Science:
- Immunology
- Metabolic Regulation
- Cancer Therapy
Background:
- Immune checkpoints (e.g., PD-1, CTLA-4) are crucial for immune cell function.
- Immune checkpoint inhibitors (ICIs) show therapeutic promise but face challenges like treatment ineffectiveness and immune resistance.
- Emerging evidence links immune checkpoints to cell metabolism, influencing immune responses and tumor progression.
Purpose of the Study:
- To review mechanisms of immune checkpoint proteins (PD-1, CTLA-4, TIGIT, TIM-3, CD47, IDO1) in regulating metabolic reprogramming.
- To explore the potential of "dual regulation" strategies targeting immune checkpoints and metabolic pathways to overcome tumor immune resistance.
Main Methods:
- Literature review of scientific articles on immune checkpoints, cell metabolism, and cancer immunology.
- Analysis of mechanisms by which specific immune checkpoints influence tumor and immune cell metabolism.
- Synthesis of findings to evaluate therapeutic strategies.
Main Results:
- Immune checkpoints modulate tumor cell metabolic reprogramming, affecting nutrient availability for immune cells.
- Immune checkpoints regulate immune cell metabolic pathways (e.g., PI3K/AKT/mTOR), impacting immune cell activation.
- Specific checkpoints like PD-1, CTLA-4, TIGIT, TIM-3, CD47, and IDO1 are implicated in metabolic regulation.
Conclusions:
- Immune checkpoint proteins significantly interact with cellular metabolism.
- Targeting immune checkpoints and metabolic pathways simultaneously offers a promising approach to enhance cancer immunotherapy efficacy and overcome resistance.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:53Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K